Edition:
United Kingdom

OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

215JPY
7:00am BST
Change (% chg)

¥1 (+0.47%)
Prev Close
¥214
Open
¥213
Day's High
¥217
Day's Low
¥213
Volume
280,100
Avg. Vol
821,607
52-wk High
¥311
52-wk Low
¥200

Chart for

About

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with... (more)
No analyst recommendations are available for .

Overall

Beta: 2.17
Market Cap(Mil.): ¥37,346.13
Shares Outstanding(Mil.): 147.03
Dividend: --
Yield (%): --

Financials

  4564.T Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -19.08 -- --
ROI: -25.32 1.58 14.38
ROE: -25.67 2.41 16.07

BRIEF-OncoTherapy Science unit says joint development with Japanese Foundation For Cancer Research

* Says co's unit Cancer Precision Medicine signs joint development agreement with Japanese Foundation For Cancer Research

01 Mar 2018

BRIEF-OncoTherapy Science unit says business alliance with Thermo Fisher Scientific

* Says its unit, Cancer Precision Medicine forms business alliance with Thermo Fisher Scientific

15 Feb 2018

Earnings vs. Estimates